We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cenix BioScience Signs Collaboration and Technology License Agreement for In Vivo siRNA Delivery

News   May 05, 2011

 
Cenix BioScience Signs Collaboration and Technology License Agreement for In Vivo siRNA Delivery
 
 
Advertisement
 

RELATED ARTICLES

Fine-Tuning the Bioproduction of Drugs

News

Researchers have developed technology that allows microbes to produce drugs with feedback control systems, dialing down or amping up protein concentration as needed.

READ MORE

Reducing Off-Target Pesticide Impacts

News

Using the pollen beetle Brassicogethes aeneus and its host crop oilseed rape as a model crop-pest system, researchers have examined how RNAi efficacy depends on the duration of dietary exposure to dsRNA. This observation has important implications for optimizing dsRNA spray approaches to managing crop pests.

READ MORE

New Generation of siRNA Could Enable New RNA Therapies

News

In a new study published in Cell Research, researchers at Nanjing University report that a new developments in synthetic biology could allow a type of gene therapy to acheive major therapeutic advances.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE